(ii) The levels of TIMP-2 and -3 increased with WHO classification of ovarian tumors particularly, with Type 2 ovarian tumors, showing greater intensity of staining of TIMP-2 than -3 relative to control. This evidence concerns the gene TIMP2 and ovarian neoplasm.